Patented technology that delivers a precise dose of oxygen to a patient, direct to the functioning area of the lung - opening up initial contracts of £7mil+. This replaces current, ineffective methods for treating patients with respiratory failure.
Target |
£1,500,000
|
Minimum |
£100,000
|
Invested |
£500,000
|
Previous Rounds | n/a |
Stage | Finished Product |
Investor Role | Any |
Sign up now to gain full access to pitches and investor profiles
global:publish_msg_immediate
global:publish_msg
You have passed the test and you may continue your with your investment.